The scaling up of operations comes as a relief given that auto sales in China had dropped 80 per cent year-on-year in February and 40 per cent in March
Even as costs are lower, demand weakness likely to keep airlines in the red for most of FY21
The company reported its highest-ever deal wins at $393 million for the quarter and $1.3 billion for FY20
FB deal puts it on course to be debt free next year; Reliance Retail biggest gainer from WhatsApp, JioMart arrangement
Galaxy Surfactants, SRF, Aarti Industries among companies to benefit given supply of essential ingredients, alternative supply chain to China and weak crude oil prices
Higher tractor margins, cash on books and better capital allocation policy are positives
With the pharma sector being rerated, given steady growth prospects and attractive valuations, all the companies, including pharma MNCs, will see greater investor interest
Weak exports and sluggish capex cycle suggest that there would be some near-term pain
The recent gains came on Monday after the company received the USFDA approval for its Nagpur facility
35% correction and long-term growth plans keep brokerages positive
Bookings at Rs 2,380 cr were twice that of the October-December period, 10% higher than year-ago quarter as firm used online sales heavily to post highest ever quarterly sales
Brokerages prefer Bajaj and Hero, given its weak financial profile and premium valuation
The pharma sector, once considered a safe bet, has been trailing the benchmark indices for four years in a row
The country accounts for 44% of overall revenues
While valuations are attractive, disruption will keep volumes muted
Analysts expect dent in near-term profits
Brokerages have cut their advertising and earnings estimates for broadcasters by up to 11 per cent
If the pandemic continues, a fifth of annual revenues could get affected
Higher share of replacement segment should help cushion demand drop
Motherson Sumi, Apollo Tyres and Tata Motors to be among the worst affected because of high exposure